Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(2)

Detailed Status

Completed2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed267%
not_yet_recruiting133%

Recent Activity

0 active trials
Showing 3 of 3
not_yet_recruitingnot_applicable

Point of Care Testing INR in Antiphospholipid Syndrome

NCT07570511
completednot_applicable

Point of Care Testing in Pediatric Patients Undergoing Major Surgery

NCT01742936
completednot_applicable

Prediction of Major Bleeding in ELBW-infants (<1000g) by Sequential Coagulation Monitoring

NCT01976013

Clinical Trials (3)

Showing 3 of 3 trials
NCT07570511Not Applicable

Point of Care Testing INR in Antiphospholipid Syndrome

Not Yet Recruiting
NCT01742936Not Applicable

Point of Care Testing in Pediatric Patients Undergoing Major Surgery

Completed
NCT01976013Not Applicable

Prediction of Major Bleeding in ELBW-infants (<1000g) by Sequential Coagulation Monitoring

Completed

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3